These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12799038)

  • 1. Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHC.
    Cohen CJ; Denkberg G; Schiffenbauer YS; Segal D; Trubniykov E; Berke G; Reiter Y
    J Immunol Methods; 2003 Jun; 277(1-2):39-52. PubMed ID: 12799038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
    Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
    J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.
    Altman JD; Davis MM
    Curr Protoc Immunol; 2016 Nov; 115():17.3.1-17.3.44. PubMed ID: 27801510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I.
    Kalergis AM; Goyarts EC; Palmieri E; Honda S; Zhang W; Nathenson SG
    J Immunol Methods; 2000 Feb; 234(1-2):61-70. PubMed ID: 10669770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide:MHC tetramer-based enrichment of epitope-specific T cells.
    Legoux FP; Moon JJ
    J Vis Exp; 2012 Oct; (68):. PubMed ID: 23117190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.
    Whelan JA; Dunbar PR; Price DA; Purbhoo MA; Lechner F; Ogg GS; Griffiths G; Phillips RE; Cerundolo V; Sewell AK
    J Immunol; 1999 Oct; 163(8):4342-8. PubMed ID: 10510374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II peptide tetramers vs allergen-induced proliferation for identification of allergen-specific CD4 T cells.
    Van Hemelen D; Mahler V; Fischer G; Fae I; Reichl-Leb V; Pickl W; Jutel M; Smolinska S; Ebner C; Bohle B; Jahn-Schmid B
    Allergy; 2015 Jan; 70(1):49-58. PubMed ID: 25236500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
    Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
    Pittet MJ; Zippelius A; Speiser DE; Assenmacher M; Guillaume P; Valmori D; Liénard D; Lejeune F; Cerottini JC; Romero P
    J Immunol; 2001 Jun; 166(12):7634-40. PubMed ID: 11390521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
    Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
    Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
    Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
    Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a static fluorescence-based cytometer: the CellScan in clinical immunology.
    Szyper-Kravitz M; Harel M; Gilburd B; Trubniykov E; Schiffenbauer YS; Shoenfeld Y
    Lupus; 2006; 15(7):436-41. PubMed ID: 16898179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing bovine T cell vaccines via reverse immunology.
    Nene V; Svitek N; Toye P; Golde WT; Barlow J; Harndahl M; Buus S; Nielsen M
    Ticks Tick Borne Dis; 2012 Jun; 3(3):188-92. PubMed ID: 22621863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.